Hemagen Diagnostics Inc - Statement of Changes in Beneficial Ownership (4)
21 Mai 2008 - 10:00PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
January 31, 2008
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
COHEN ALAN SEYMOUR
|
2. Issuer Name
and
Ticker or Trading Symbol
HEMAGEN DIAGNOSTICS INC
[
HMGN
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
54 WINSTON ROAD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/20/2008
|
(Street)
NEWTOWN, MA 02459
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
|
|
|
|
|
|
|
256626
|
I
|
By trusts
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Options
|
$.35
|
5/20/2008
|
|
A
|
|
5000
(1)
|
|
5/20/2008
|
5/20/2018
|
Common Stock
|
5000
|
$0
|
5000
|
D
|
|
Stock Options
|
$.35
|
5/20/2008
|
|
A
|
|
5000
(2)
|
|
5/20/2008
|
5/20/2018
|
Common Stock
|
5000
|
$0
|
5000
|
D
|
|
Stock Options
|
$.35
|
5/20/2008
|
|
A
|
|
10000
(2)
|
|
5/20/2008
|
5/20/2018
|
Common Stock
|
10000
|
$0
|
10000
|
D
|
|
Stock Options
|
$.25
|
5/20/2008
|
|
A
|
|
5000
(3)
|
|
5/20/2008
|
5/20/2018
|
Common Stock
|
5000
|
$0
|
5000
|
D
|
|
Stock Options
|
$.14
|
5/20/2008
|
|
A
|
|
5000
(4)
|
|
5/20/2008
|
5/20/2018
|
Common Stock
|
5000
|
$0
|
5000
|
D
|
|
Explanation of Responses:
|
(
1)
|
Granted pursuant to 2007 Stock Incentive Plan for awards owed for service as a director for the fiscal year ending September 30, 2004; exercise price reflects closing price as of March 18, 2005, the date reporting person was otherwise entitled to receive the award.
|
(
2)
|
Granted pursuant to 2007 Stock Incentive Plan for awards owed for service as a director for the fiscal year ending September 30, 2005; exercise price reflects closing price as of March 3, 2006, the date reporting person was otherwise entitled to receive the award.
|
(
3)
|
Granted pursuant to 2007 Stock Incentive Plan for awards owed for service as a director for the fiscal year ending September 30, 2006; exercise price reflects closing price as of April 24, 2007, the date reporting person was otherwise entitled to receive the award.
|
(
4)
|
Granted pursuant to 2007 Stock Incentive Plan for awards owed for service as a director for the fiscal year ending September 30, 2007.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
COHEN ALAN SEYMOUR
54 WINSTON ROAD
NEWTOWN, MA 02459
|
X
|
|
|
|
Signatures
|
/s/William P. Hales as Attorney-in-Fact for Alan S. Cohen
|
|
5/21/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Hemagen Diagnostics (CE) (USOTC:HMGN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Hemagen Diagnostics (CE) (USOTC:HMGN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Hemagen Diagnostics Inc (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur Hemagen Diagnostics Inc